Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

Introduction and Objectives. Neutrophil-to-lymphocyte ratio (NLR) has been suggested to be a simple marker of the systemic inflammatory response in critical care patients. We previously assessed the utility of NLR as a biomarker to predict tumor recurrence and cancer death in bladder cancer patients...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed Res Int
Autors principals: Ohtake, Shinji, Kawahara, Takashi, Kasahara, Ryo, Ito, Hiroki, Osaka, Kimito, Hattori, Yusuke, Teranishi, Jun-ichi, Makiyama, Kazuhide, Mizuno, Nobuhiko, Umemoto, Susumu, Miyoshi, Yasuhide, Nakaigawa, Noboru, Miyamoto, Hiroshi, Yao, Masahiro, Uemura, Hiroji
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2016
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5086366/
https://ncbi.nlm.nih.gov/pubmed/27822480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/9846823
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars